Polycystic ovary syndrome affects roughly one in ten people of reproductive age in the United States, and most spend years seeing clinicians before anyone names it. The name is part of the problem: it says “cysts,” when PCOS is really a whole-body hormonal and metabolic pattern. This guide covers the symptom cluster, how the Rotterdam criteria decide the diagnosis, and which labs matter.
What is PCOS?
PCOS is a condition in which ovulation becomes irregular or stops, androgen levels run higher than typical, and the body’s response to insulin is often blunted. Those threads reinforce each other: higher insulin pushes the ovaries toward more androgen, and more androgen disrupts egg maturation.
“Polycystic” is the biggest source of confusion. What an ultrasound sees is not cysts in the everyday sense. Those small round structures are follicles — the ordinary sacs every ovary contains, each holding an immature egg. In PCOS they are simply more numerous and tend to stall early.
Ovarian cysts are therefore not required for a diagnosis, and many people meet the criteria with ovaries that look unremarkable on imaging. That mismatch drove a formal change of name: in 2026 an international consensus process renamed the condition polyendocrine metabolic ovarian syndrome, or PMOS, and Cleveland Clinic and Mayo Clinic now publish it under that name. PCOS is the former name and PMOS the current one, so a report or clinician using the newer term is not describing something different from what you were diagnosed with.
Symptoms and warning signs
PCOS presents as a cluster, and almost nobody has every feature.
Skin and hair signs
Hirsutism — coarse, dark, male-pattern hair on the upper lip, chin, chest or abdomen — is among the most reliable clinical markers of androgen excess. Dermatologists also frequently evaluate the hormonally driven acne pattern that clusters along the jawline and chin. Scalp hair moves the other way, thinning at the crown while the frontal hairline is preserved. Acanthosis nigricans, a velvety darkening of skin in the neck or armpit folds, signals high insulin.
Cycle and fertility signs
Irregular ovulation is the cycle signature: periods arriving fewer than eight or nine times a year, gaps of several months, or none at all. Difficulty conceiving is often what finally brings someone in. PCOS is the leading cause of anovulatory infertility, meaning infertility caused by eggs not being released rather than by any blockage. It is also among the most treatable causes: ovulation can usually be restored, and most people with PCOS who want to become pregnant eventually do.
How PCOS is diagnosed
No single test settles it. Adults are diagnosed using the Rotterdam criteria: two of three features, once conditions that imitate PCOS are excluded:
- Irregular or absent ovulation, judged from cycle history.
- Hyperandrogenism, clinical (hirsutism, acne, scalp thinning) or biochemical.
- Polycystic ovarian morphology on ultrasound.
An adult who already meets the first two criteria does not need an ultrasound, and the 2023 international guideline now accepts an anti-Müllerian hormone blood level as an alternative to imaging in adults. Adolescents are handled differently, because irregular cycles and multifollicular ovaries are both normal in the years after a first period.
The blood tests that matter
Bloodwork does two jobs: it confirms androgen excess and excludes mimics. A workup almost always includes a testosterone blood test that quantifies the degree of androgen excess, but that value alone misleads, because most circulating testosterone is bound and inert. Clinicians therefore add an SHBG measurement that reveals how much testosterone is free to act on tissue.
| Test | What it reflects | Typical PCOS pattern |
|---|---|---|
| Total testosterone | All circulating testosterone | Normal to modestly raised; markedly high argues against PCOS |
| SHBG | Protein holding testosterone inactive | Often low, especially when insulin is high |
| Free androgen index | Ratio of testosterone to SHBG | Often high even when total testosterone reads normal |
| DHEA-S | Adrenal androgen | Usually normal; very high points to an adrenal cause |
| LH and FSH | Pituitary drivers of follicle growth | LH often proportionally higher than FSH; supportive, never diagnostic |
| AMH | Proxy for small-follicle number | Typically elevated; an accepted alternative to ultrasound in adults only |
| Prolactin | Suppresses ovulation when high | Normal; ordered to exclude hyperprolactinemia |
| 17-OH progesterone | Adrenal steroid precursor | Normal; elevation suggests non-classic congenital adrenal hyperplasia |
| TSH | Thyroid signal from the pituitary | Normal; abnormal values point to thyroid disease instead |
| Fasting glucose and insulin | Blood sugar and the insulin holding it | Glucose often normal while insulin runs high — the fingerprint of insulin resistance |
| Lipid panel | Cholesterol fractions and triglycerides | Higher triglycerides and LDL with lower HDL are common |
Hormonal contraception suppresses several of these values, so discuss timing first.
PCOS phenotypes: why no two cases look alike
Because Rotterdam requires any two of three features, PCOS is four presentations, labeled A to D. A has all three. B has androgen excess plus irregular ovulation. C has androgen excess plus polycystic ovaries, with ovulation intact. D has irregular ovulation plus polycystic ovaries, without androgen excess. The phenotypes carrying androgen excess sit with more metabolic risk.
Lean PCOS belongs here. The condition occurs across the whole body-size spectrum, and a substantial share of people who have it are slim. It is not a milder disease: insulin resistance is common here too, just less visible, which is why it gets missed for years. Many panels also report a luteinizing hormone level that reflects the pituitary signal driving ovulation.
Causes and risk factors
Insulin resistance sits near the center. When cells respond poorly to insulin, the pancreas releases more, and that excess raises ovarian androgen output while lowering SHBG. Clinicians therefore order a fasting insulin test that estimates how hard the pancreas is working, since glucose looks reassuring long after insulin has climbed.
Androgen excess is the second engine, arising in the ovary, the adrenal gland, or both. Genetics carry real weight: PCOS clusters in families, and genome-wide studies point to variants affecting insulin signaling and follicle development.
PCOS is not caused by anything you did, ate, or failed to do. Body size modifies the condition rather than originating it.
Conditions PCOS is confused with
Thyroid disease comes first because it is common and easy to test: both underactive and overactive thyroid disrupt cycles, and hypothyroidism can raise prolactin. Non-classic congenital adrenal hyperplasia is a partial enzyme deficiency causing adrenal androgen overproduction, so endocrinologists order a 17-OH progesterone level drawn in the early morning.
Hyperprolactinemia, usually from a benign pituitary adenoma or certain medications, suppresses ovulation, so clinicians order a prolactin test that screens for a pituitary cause of absent cycles. Cushing’s syndrome adds easy bruising, purple stretch marks and muscle weakness; testing is reserved for those extra signs.
Treatment options
Treatment is organized around goals. Medications below are described by class and purpose only; whether to start or stop anything is a decision for you and your clinician.
For cycle regulation and endometrial protection, combined hormonal contraceptives are usually first-line: they restore predictable bleeding, protecting the lining from unopposed estrogen, and raise SHBG, which lowers free androgen. Cyclic progestin therapy is an alternative when estrogen is unsuitable.
For androgen-driven skin and hair symptoms, options include anti-androgen medications, hormonal contraception, topical prescriptions, and procedures such as laser reduction or electrolysis — all slow, since hair follicles run on a months-long cycle.
For fertility, ovulation induction is the mainstay and the outlook is genuinely good. Aromatase inhibitors have largely displaced older selective estrogen receptor modulators as first-line agents; gonadotropins are second-line, and in vitro fertilization follows if earlier steps fail.
For metabolic risk, insulin-sensitizing medication is used in some situations, with lipid and blood pressure care following standard prevention practice. Movement and eating patterns matter here, but the useful version of that advice is qualitative: activity you can sustain, and an eating pattern built with a registered dietitian. Disordered eating is more common in PCOS than in the general population, and restrictive prescriptions handed out without support can do real harm. The 2023 guideline asks clinicians to stay aware of weight stigma. Body size is one clinical factor among several, not the headline and not the fix.
Long-term health risks to monitor
The risk of impaired glucose tolerance and type 2 diabetes runs well above the general population; the CDC notes that more than half of women with PCOS develop it by age 40. Screening usually includes a fasting glucose measurement repeated at intervals your clinician sets. Gestational diabetes is also more common, so prenatal screening starts earlier.
The clustering of unfavorable lipids, higher blood pressure and insulin resistance means cardiovascular assessment should begin earlier and repeat more often. Obstructive sleep apnea is more prevalent too, and worsens insulin resistance.
Endometrial risk stems directly from anovulation: with no progesterone phase, the lining sees estrogen unopposed, raising the long-term risk of endometrial hyperplasia and cancer — the clinical reason behind cycle regulation. Mental health belongs here too — depression, anxiety and body image distress all occur at higher rates, and the 2023 guideline flags psychological features as very highly prevalent and under-addressed.
Living with PCOS: daily management
Tracking cycles gives your clinician real data instead of recollection, and a ranked symptom list keeps appointments focused. Regular movement improves insulin sensitivity independently of any change in body size — the benefit shows up in bloodwork whether or not the scale moves.
Build a team rather than relying on one appointment a year: primary care, gynecology, endocrinology, dermatology, a dietitian and a mental health professional. Recheck labs on the schedule your clinician sets, and be skeptical of supplements marketed for PCOS.
Latest scientific advances
The most consequential recent development is not a drug but a rulebook. An international panel led by Helena Teede assembled 39 organizations across 71 countries and commissioned 52 systematic reviews (studies pooling all available evidence rather than relying on one trial) to produce the 2023 International Evidence-based Guideline. It delivered 254 recommendations and practice points, 77 of them evidence-based. Anti-Müllerian hormone testing was accepted as an alternative to ultrasound in adults only (Teede et al., 2023). What this means for you: as an adult with irregular cycles plus documented androgen excess, you do not need an ultrasound to be diagnosed.
A 2025 companion paper in BMC Medicine applied the same process to teenagers across 55 clinical questions and concluded that adolescents need different rules: diagnosis before adulthood requires both irregular cycles and clinical or biochemical hyperandrogenism. Critically, neither pelvic ultrasound nor anti-Müllerian hormone should be used to diagnose PCOS during adolescence, because both are unreliable at that age; teenagers with one feature are classified as “at risk” and followed (Peña et al., 2025). What this means for you: if a teenager was diagnosed on an ultrasound alone, that is worth revisiting.
A 2023 meta-analysis (a study statistically combining results from multiple trials) in Reproductive Biology and Endocrinology pooled 26 randomized controlled trials covering 1,691 participants. Those taking inositol were 1.79 times as likely to achieve a regular menstrual cycle as those on placebo, with a 95% confidence interval of 1.13 to 2.85 — the range where the true effect very likely sits, and because it stays above 1.0 the result is unlikely to be chance. Inositol also lowered free testosterone and raised SHBG (Greff et al., 2023). What this means for you: this is among the better-evidenced supplements in PCOS, but not necessarily right for you.
Myths and facts
- Myth: you must have ovarian cysts to have PCOS. Fact: the ultrasound finding is one of three criteria and only two are needed.
- Myth: PCOS only affects people in larger bodies. Fact: lean PCOS is real and common.
- Myth: PCOS means you cannot have children. Fact: it is the leading cause of anovulatory infertility, and among the most treatable.
- Myth: hormonal contraception just masks the problem. Fact: it treats real problems and does not delay a later return to fertility.
- Myth: PCOS is caused by lifestyle choices. Fact: its origins are genetic, hormonal and developmental.
Glossary
| Term | Meaning |
|---|---|
| Anovulation | A cycle in which no egg is released |
| Androgen | A hormone such as testosterone or DHEA-S |
| Hyperandrogenism | Androgen excess, on the body or in bloodwork |
| Hirsutism | Coarse dark hair in a male-pattern distribution |
| Insulin resistance | Reduced cellular response to insulin |
| Follicle | A fluid-filled ovarian sac holding an immature egg |
| Rotterdam criteria | The two-of-three diagnostic standard for adults |
Frequently asked questions
How is PCOS diagnosed?
Adults are diagnosed using the Rotterdam criteria: two of three features, namely irregular or absent ovulation, clinical or biochemical androgen excess, and polycystic ovaries on ultrasound. Conditions producing the same picture — thyroid disease, non-classic congenital adrenal hyperplasia and high prolactin — must be excluded first, which is why a workup includes tests expected to read normal. If you already meet the first two criteria, imaging adds nothing.
Can you get pregnant with PCOS?
Yes, and most people who want to eventually do. PCOS is the leading cause of anovulatory infertility: the difficulty comes from eggs not being released rather than from a blockage, and that responds well to treatment. Ovulation induction with an aromatase inhibitor is usually the first step, with insulin-sensitizing medication, gonadotropins or in vitro fertilization if needed. Some people conceive without any intervention.
What causes PCOS?
There is no single cause. Three mechanisms reinforce one another: insulin resistance, which drives ovarian androgen production and lowers SHBG; androgen excess itself, which disrupts follicle maturation and the brain-ovary feedback loop; and genetics, since PCOS clusters strongly in families. Prenatal hormone exposure is under active study. What is clear is that PCOS is not caused by anything a person did or failed to do.
Can you have PCOS if you are not overweight?
Yes. Lean PCOS is well recognized, and a meaningful share of people with the condition are slim. It is not a milder variant: insulin resistance is common in this group too, simply harder to spot without bloodwork, and androgen symptoms can be just as pronounced. The practical problem is diagnostic delay, because clinicians sometimes assume a slim build rules PCOS out.
Does PCOS cause hair loss?
It can. Androgen excess affects scalp follicles in a pattern called androgenic alopecia, producing gradual thinning at the crown and part line while the frontal hairline stays intact. This can coexist with unwanted hair growth elsewhere, because scalp and body follicles respond to androgens in opposite directions. Treatment targets the androgen excess, and progress is slow because follicles work on a months-long cycle.
Does PCOS ever go away?
PCOS is lifelong rather than something that resolves, but its presentation shifts. Cycles often become more regular in the late thirties and forties, and after menopause the cycle and fertility features no longer apply. Symptoms are genuinely controllable in the meantime, since androgen symptoms, cycle irregularity and metabolic markers all respond to treatment. What persists is the metabolic and cardiovascular risk profile.
Sources
- NICHD — Polycystic Ovary Syndrome (PCOS) — National Institutes of Health, 2024 — nichd.nih.gov
- Office on Women’s Health — Polycystic ovary syndrome — HHS, 2024 — womenshealth.gov
- Centers for Disease Control and Prevention — Diabetes and Polycystic Ovary Syndrome (PCOS) — CDC, 2024 — cdc.gov
- Mayo Clinic — Polyendocrine metabolic ovarian syndrome (PMOS) — Mayo Clinic, 2026 — mayoclinic.org
- Cleveland Clinic — PMOS (Polyendocrine Metabolic Ovarian Syndrome) — Cleveland Clinic, 2026 — my.clevelandclinic.org
- Teede HJ et al. — Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome — Human Reproduction, 2023 — doi.org
- Peña AS et al. — International evidence-based recommendations for polycystic ovary syndrome in adolescents — BMC Medicine, 2025 — doi.org
- Greff D et al. — Inositol is an effective and safe treatment in PCOS — Reproductive Biology and Endocrinology, 2023 — doi.org
Further reading
- If your panel showed an adrenal pattern, we explain how to read a DHEA-S result and what an elevated value suggests.
- Because thyroid disease is the first mimic excluded, it helps to understand what a TSH result reveals about thyroid function.
- The metabolic side of PCOS makes sense once you follow the mechanisms connecting insulin resistance to type 2 diabetes.
- If your glucose looks fine but symptoms do not, we unpack why an A1c can miss early insulin resistance entirely.
- Painful periods alongside irregular cycles can point elsewhere, so review the symptoms that distinguish endometriosis from PCOS.
Understand your lab results with BloodSense
PCOS is a condition where the lab report tells most of the story, and is hardest to read alone. A typical panel spans testosterone, SHBG, free androgen index, DHEA-S, LH and FSH, AMH, prolactin, 17-OH progesterone, TSH, fasting glucose and insulin, and lipids — and individually, many land inside their reference ranges. The diagnosis lives in the relationships between them: a normal testosterone with a low SHBG, a normal glucose with a high insulin.
BloodSense reads your results as a pattern rather than isolated values, explains what each marker reflects in plain language, and shows which combinations are worth raising at your next appointment. It does not replace your clinician; it makes that conversation more useful.
